Why Veru Inc.’s (VERU) Stock Is Down 11.76%
As of Monday, June 08, Veru Inc.’s VERU share price has dipped by 11.76%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Commentary & Analysis
Why Veru Inc.’s (VERU) Stock Is Down 7.52%
As of Friday, June 05, Veru Inc.’s VERU share price has dipped by 7.52%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Veru Inc.’s (VERU) Stock Is Down 12.06%
As of Friday, June 05, Veru Inc.’s VERU share price has dipped by 12.06%, which has investors questioning if this is right time to buy.Omar Beirat
Why Veru Inc.’s (VERU) Stock Is Down 18.57%
As of Thursday, October 30, Veru Inc.’s VERU share price has dipped by 18.57%, which has investors questioning if this is right time to buy.Omar Beirat
Why Veru Inc.’s (VERU) Stock Is Up 5.11%
As of Friday, October 24, Veru Inc.’s VERU share price has surged by 5.11%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | VERU | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $45.0 | $674.5 | 15% |
|
| Shares Out (Mil) | 23.1 | 43.5 | 32% |
|
| Institutional Ownership | 62.4% | 84.6% | 39% |
|
| Float (Mil) | 15.5 | 47.3 | 25% |
|
| Beta | -1.20 | 0.71 | 1% |
|
| Avg Daily Volume (000s) | 159 | 290 | 43% |
|
| Price Change (52-week) |
(20.0%) | 69.3% | 30% |
|
| Growth | VERU | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | (3.6%) | (1.4%) | 35% |
|
| EPS (5yr) | 11.4% | 15.0% | 49 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (20.8%) | (15.0%) | 32% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.325) | ($1.195) | ($0.985) | |
| Month Ago EPS | ($0.325) | ($1.195) | ($0.985) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | ($0.325) | ($1.195) | ($0.985) | |
| Year/Year Chg | 7.3% | 11.6% | (38.4%) | |
| Financials | VERU | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $317 | na |
|
| Net Income (TTM) (Mil) | ($14) | ($11) | 27% |
|
| EPS (TTM) | ($0.672) | ($0.700) | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($26) | ($6) | 13% |
|
| Net Cash Flow (TTM) (Mil) | na | $5 | na |
|
| Long-Term Debt (Q1) (Mil) | $2 | $6 | 20% |
|
| Enterprise Value (Q1) (Mil) | $21 | $536 | 11% |
|
| Valuation | VERU | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.59 | 2.80 | 41% |
|
| P/E | na | 17.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VERU | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 68.1% | na |
|
| Net Margin | na | (1.4%) | na |
|
| ROA | (42.3%) | (24.1%) | 13% |
|
| ROE | (62.3%) | (21.0%) | 13% |
|
| Liabilities to Assets | 23.4% | 32.3% | 16% |
|
| F-Score | 2 | 3 | 7% |
|
Veru Inc. did not pass any screens on 9/4/2026.
